IBDEI0MM ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,10165,1,4,0)
 ;;=4^E10.3211
 ;;^UTILITY(U,$J,358.3,10165,2)
 ;;=^5138279
 ;;^UTILITY(U,$J,358.3,10166,0)
 ;;=E10.3212^^39^430^20
 ;;^UTILITY(U,$J,358.3,10166,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10166,1,3,0)
 ;;=3^DM Type 1 w/ Mild Nonp Rtnop w/ Macular Edema,Lt Eye
 ;;^UTILITY(U,$J,358.3,10166,1,4,0)
 ;;=4^E10.3212
 ;;^UTILITY(U,$J,358.3,10166,2)
 ;;=^5138280
 ;;^UTILITY(U,$J,358.3,10167,0)
 ;;=E10.3213^^39^430^21
 ;;^UTILITY(U,$J,358.3,10167,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10167,1,3,0)
 ;;=3^DM Type 1 w/ Mild Nonp Rtnop w/ Macular Edema,Bilat
 ;;^UTILITY(U,$J,358.3,10167,1,4,0)
 ;;=4^E10.3213
 ;;^UTILITY(U,$J,358.3,10167,2)
 ;;=^5138281
 ;;^UTILITY(U,$J,358.3,10168,0)
 ;;=E10.39^^39^430^26
 ;;^UTILITY(U,$J,358.3,10168,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10168,1,3,0)
 ;;=3^DM Type 1 w/ Oth Diab Ophth Compl
 ;;^UTILITY(U,$J,358.3,10168,1,4,0)
 ;;=4^E10.39
 ;;^UTILITY(U,$J,358.3,10168,2)
 ;;=^5002603
 ;;^UTILITY(U,$J,358.3,10169,0)
 ;;=E10.40^^39^430^10
 ;;^UTILITY(U,$J,358.3,10169,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10169,1,3,0)
 ;;=3^DM Type 1 w/ Diab Neuropathy,Unspec
 ;;^UTILITY(U,$J,358.3,10169,1,4,0)
 ;;=4^E10.40
 ;;^UTILITY(U,$J,358.3,10169,2)
 ;;=^5002604
 ;;^UTILITY(U,$J,358.3,10170,0)
 ;;=E10.41^^39^430^7
 ;;^UTILITY(U,$J,358.3,10170,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10170,1,3,0)
 ;;=3^DM Type 1 w/ Diab Mononeuropathy
 ;;^UTILITY(U,$J,358.3,10170,1,4,0)
 ;;=4^E10.41
 ;;^UTILITY(U,$J,358.3,10170,2)
 ;;=^5002605
 ;;^UTILITY(U,$J,358.3,10171,0)
 ;;=E10.42^^39^430^11
 ;;^UTILITY(U,$J,358.3,10171,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10171,1,3,0)
 ;;=3^DM Type 1 w/ Diab Polyneuropathy
 ;;^UTILITY(U,$J,358.3,10171,1,4,0)
 ;;=4^E10.42
 ;;^UTILITY(U,$J,358.3,10171,2)
 ;;=^5002606
 ;;^UTILITY(U,$J,358.3,10172,0)
 ;;=E10.43^^39^430^2
 ;;^UTILITY(U,$J,358.3,10172,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10172,1,3,0)
 ;;=3^DM Type 1 w/ Diab Autonomic Polyneuropathy
 ;;^UTILITY(U,$J,358.3,10172,1,4,0)
 ;;=4^E10.43
 ;;^UTILITY(U,$J,358.3,10172,2)
 ;;=^5002607
 ;;^UTILITY(U,$J,358.3,10173,0)
 ;;=E10.44^^39^430^1
 ;;^UTILITY(U,$J,358.3,10173,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10173,1,3,0)
 ;;=3^DM Type 1 w/ Diab Amyotrophy
 ;;^UTILITY(U,$J,358.3,10173,1,4,0)
 ;;=4^E10.44
 ;;^UTILITY(U,$J,358.3,10173,2)
 ;;=^5002608
 ;;^UTILITY(U,$J,358.3,10174,0)
 ;;=E10.49^^39^430^25
 ;;^UTILITY(U,$J,358.3,10174,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10174,1,3,0)
 ;;=3^DM Type 1 w/ Oth Diab Neurological Compl
 ;;^UTILITY(U,$J,358.3,10174,1,4,0)
 ;;=4^E10.49
 ;;^UTILITY(U,$J,358.3,10174,2)
 ;;=^5002609
 ;;^UTILITY(U,$J,358.3,10175,0)
 ;;=E10.59^^39^430^22
 ;;^UTILITY(U,$J,358.3,10175,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10175,1,3,0)
 ;;=3^DM Type 1 w/ Oth Circulatory Compl
 ;;^UTILITY(U,$J,358.3,10175,1,4,0)
 ;;=4^E10.59
 ;;^UTILITY(U,$J,358.3,10175,2)
 ;;=^5002612
 ;;^UTILITY(U,$J,358.3,10176,0)
 ;;=E10.610^^39^430^9
 ;;^UTILITY(U,$J,358.3,10176,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10176,1,3,0)
 ;;=3^DM Type 1 w/ Diab Neuropathic Arthropathy
 ;;^UTILITY(U,$J,358.3,10176,1,4,0)
 ;;=4^E10.610
 ;;^UTILITY(U,$J,358.3,10176,2)
 ;;=^5002613
 ;;^UTILITY(U,$J,358.3,10177,0)
 ;;=E10.618^^39^430^23
 ;;^UTILITY(U,$J,358.3,10177,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10177,1,3,0)
 ;;=3^DM Type 1 w/ Oth Diab Arthropathy
